Brief: Arix Bioscience eyes up to $75 mln in U.S. IPO

Arix Bioscience

10/10/2018 07:04

Oct 10 (Reuters) - Arix Bioscience PLC  ARIX.L :
    * SAYS REGISTRATION STATEMENT DISCLOSES AN INDICATIVE
PRICING
RANGE FOR PROPOSED OFFERING OF U.S.$12.00- U.S.$14.00 PER COMMON
SHARE
    * SAYS PROPOSED MAXIMUM AGGREGATE OFFERING AMOUNT SPECIFIED
IN
FILING IS U.S.$75.0 MILLION

Source text for Eikon:  ID: 
Further company coverage:  ARIX.L 

 (Reporting By Simon Jessop)
 ((simon.jessop@thomsonreuters.com;))